FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096821 [Registered on: 03/11/2025] Trial Registered Prospectively
Last Modified On: 31/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study To see the effect of two species of Roscoea in low sperm count  
Scientific Title of Study   Comparative clinical evaluation of two species of Roscoea in Oligozoospermia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jai Shree Yadav  
Designation  Pg scholar  
Affiliation  Patanjali bhartiya ayurvigyan evam anusandhan sansthan haridwar uttarakhand  
Address  OPD No 29 Patanjali ayurved hospital patanjali yogpeeth phase 1 Bahadrabaad haridwar uttarakhand
OPD No 29 Patanjali ayurved hospital patanjali yogpeeth phase 1 Bahadrabaad haridwar uttarakhand
Hardwar
UTTARANCHAL
249405
India 
Phone  7976841478  
Fax    
Email  jaiishree.yadavv100@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ramakant Mrade  
Designation  Professor and HOD 
Affiliation  Patanjali bhartiya ayurvigyan evam anusandhan sansthan haridwar uttarakhand  
Address  OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand
OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand
Hardwar
UTTARANCHAL
249405
India 
Phone  9720982896  
Fax    
Email  ramakant.marde@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jai Shree Yadav  
Designation  Pg scholar  
Affiliation  Patanjali bhartiya ayurvigyan evam anusandhan sansthan haridwar uttarakhand  
Address  OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand
OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand
Hardwar
UTTARANCHAL
249405
India 
Phone  7976841478  
Fax    
Email  jaiishree.yadavv100@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand pin 249405 
 
Primary Sponsor  
Name  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand  
Address  OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jai Shree Yadav  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan  OPD No 29 Patanjali Ayurved Hospital Patanjali Yogpeeth Phase 1 Bahadrabaad Haridwar Uttarakhand
Hardwar
UTTARANCHAL 
7976841478

jaiishree.yadavv100@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE PATANJALI AYURVED COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: SUKRAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kakoli Roscoea alpina, Reference: Raj Nighantu Guduchiyaadi varga shloka no 27, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Cow milk ), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Kakoli Roscoea purpurea , Reference: Raj nighantu guduchiyadi varga shloka no 27, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -cow milk ), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  45.00 Year(s)
Gender  Male 
Details  1. Sperm count mild oligozoospermia (10-15 million sperms /ml) & moderate oligozoospermia
(5-10million sperms /ml)
2. Willing to sign the consent form and to participate in study.
3. Willing to give specimen of semen before and at the end of the clinical trial.
4. Abstinence during treatment. 
 
ExclusionCriteria 
Details  1. Azoospermia, Aspermia, Necrospermia
2. Patients with abnormal liver and renal functions test.
3. Subject with history of severe systemic illness like chronic renal failure, coronary artery
disease, liver cirrhosis, cancer etc.
4. Varicocele, hydrocele, prostatitis, erectile dysfunction, male accessory gland infection.
5. History of undescended testis, mumps orchitis, inguinal hernia.
6. Known case of uncontrolled diabetes, hypertension, thyroid disease.
7. Sexually transmitted disease patients presenting with organic defects.
8. History of obstruction of ejaculatory ducts (seminal vesicle, vas deferens) postsurgical
procedure or post trauma on the genital organs.
9. Testicular cancer and cancer treatment. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Dorbalya (genera debility)
2. Mukhshosha
3. Panduta (pallor)
4. Shrama (easy fatigability)
5. Sadan (boydache) 
30 days, 45 days 
 
Secondary Outcome  
Outcome  TimePoints 
1. Semen analysis
2. CBC, RBS
3. Urine (Routine and microscopic) 
30 days, 45 days  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is comparative clinical trial of two species of Roscoea in oligozoospermia. 
This will be conducted on 60 male participants with oligozoospermia will be selected randomly from outdoor patients of Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan, Haridwar. Subject will be selected irrespective of their religion, occupation. Patient will be divided randomly into two groups each group will have 30 patients on the basis of inclusion and exclusion criteria. Follow up will be taken after 30th  day and 45th day of treatment.
 
Close